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Background.  —  Coronary  angiography  (CA),  an  invasive  and  expensive  procedure,  is  still  recom-
mended  in  most  patients  referred  for  elective  valve  surgery.  Multislice  computed  tomography
(MSCT) is  a  promising  alternative  technique  to  rule  out  signiﬁcant  coronary  artery  lesions.
Aim. —  To  evaluate  MSCT  in  detecting  signiﬁcant  coronary  artery  lesions  in  patients  referred
for elective  valve  surgery.
Methods.  —  Between  August  2007  and  December  2010,  patients  referred  for  elective  valve
surgery were  identiﬁed  prospectively  and  underwent  64-slice  MSCT  and  CA.  We  compared  sig-
niﬁcant coronary  stenoses,  deﬁned  as  a  reduction  of  luminal  diameter  ≥  50%,  to  establish  the
diagnostic  accuracy  of  MSCT.  All  coronary  segments  were  analysed  and  uninterpretable  lesions
were scored  positive.
Results.  —  Forty-eight  patients  were  included  (62.5%  male;  mean  age  65  ±  12  years),  the  majo-
rity had  aortic  insufﬁciency  (37.7%)  or  aortic  stenosis  (32.0%).  The  prevalence  of  signiﬁcant
coronary artery  stenoses  was  27.1%.  The  sensitivity,  speciﬁcity,  positive  and  negative  predictive
values of  MSCT  were  77%,  89%,  71%  and  91%,  respectively,  in  a  patient-based  analysis;  82%,
Abbreviations: AHA, American Heart Association; CA, coronary angiography; CABG, coronary artery bypass graft; CAD, coronary artery
isease; CI, conﬁdence interval; IQR, interquartile range; MR, mitral regurgitation; MSCT, multislice computed tomography.
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86%,  64%  and  94%  in  a  revascularization-based  analysis;  67%,  94%,  52%  and  97%  in  a  vessel-based
analysis; and  65%,  98%,  52%  and  99%  in  a  segment-based  analysis.  Overall,  CA  could  have  been
avoided in  65%  of  patients.
Conclusion.  —  In  patients  referred  for  elective  valve  surgery,  MSCT  had  a  high  diagnostic
accuracy to  rule  out  signiﬁcant  coronary  stenoses.  However,  larger  multicenter  studies  in  an  uns-
elected population  of  patients  are  needed  to  determine  its  place  within  the  range  of  diagnostic
tool in  the  preoperative  assessment  of  valvular  heart  disease.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  La  coronarographie  est  un  examen  coûteux  et  invasif,  toujours  recommandé  chez
les patients  programmés  pour  une  chirurgie  valvulaire.  La  tomodensitométrie  multicoupe
(TDMC) apparaît  comme  une  alternative  prometteuse  pour  éliminer  les  sténoses  coronaires
signiﬁcatives.
Objectif. —  Pour  évaluer  la  précision  diagnostique  de  la  TDMC  dans  l’évaluation  de  la  maladie
coronaire  avant  la  chirurgie  valvulaire  cardiaque.
Méthodes.  —  Entre  août  2007  et  décembre  2010,  les  patients  adressés  pour  une  chirurgie  de
remplacement  valvulaire  ont  été  inclus  pour  effectuer  de  manière  prospective  une  TDMC  et  une
coronarographie.  On  a  comparé  les  sténoses  coronaires  signiﬁcatives,  déﬁnies  par  la  réduction
du diamètre  luminal  supérieur  ou  égal  à  50  %,  pour  établir  la  précision  diagnostique  de  la  TMDC.
Les lésions  ininterprétables  ont  été  considérées  positives.
Résultats.  —  Quarante-huit  patients  ont  été  inclus  (62,5  %  de  sexe  masculin  ;  âge  moyen  de
65 ±  12  ans),  la  majorité  avait  une  insufﬁsance  aortique  (37,7  %)  ou  un  rétrécissement  aortique
(32,0 %).  La  prévalence  de  la  maladie  coronaire  était  de  27,1  %.  La  sensibilité,  spéciﬁcité,  les
valeurs prédictives  positives  et  négatives  de  la  TDMC  étaient  respectivement  de  77  %,  89  %,  71  %
et 91  %  en  analyse  par  patient  ;  82  %,  86  %,  64  %  et  94  %  en  analyse  par  revascularisation  ;  67  %,
94 %,  52  %  et  97  %  en  analyse  par  artère  ;  et  65  %,  98  %,  52  %  et  99  %  en  analyse  par  segment.  La
coronarographie  aurait  pu  être  évitée  chez  64,5  %  des  patients.
Conclusion.  —  Chez  les  patients  programmés  pour  une  chirurgie  valvulaire,  la  TDMC  bénéﬁcie
d’une bonne  précision  diagnostique  pour  exclure  les  sténoses  coronaires  signiﬁcatives.  Toute-
fois, de  larges  études  multicentriques  portant  sur  une  population  non  sélectionnée  de  patients,
sont nécessaires  pour  déterminer  sa  place  au  sein  de  l’arsenal  diagnostique  dans  l’évaluation
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Background
Various  studies  have  shown  that  combined  bypass  and  valve
surgery  of  signiﬁcant  coronary  artery  disease  (CAD)  reduces
early  and  late  mortality  [1].  Coronary  angiography  (CA)  is
the  gold  standard  for  diagnosing  CAD,  and  is  recommended
in  patients  scheduled  for  valve  surgery  [2].  However,  CA  is  an
invasive  and  expensive  procedure,  with  a  small  (0.1—0.2%)
risk  of  major  complications  such  as  death,  myocardial  infarc-
tion  and  stroke.  A  primary  non-invasive  technique  as  an
alternative  to  CA  to  improve  preoperative  risk  stratiﬁca-
tion  in  patients  referred  for  valve  surgery  is  therefore  highly
desirable.
Multislice  computed  tomography  (MSCT)  has  a  good
negative  predictive  value  for  ruling  out  CAD  in  patients
with  intermediate  pre-test  probability  [3].  However,  few
studies  have  examined  coronary  artery  assessment  by
MSCT  in  patients  scheduled  for  elective  valve  surgery
[4,5].
We  conducted  a  prospective  study  to  evaluate  the  diag-
nostic  accuracy  of  64-slice  MSCT  for  the  detection  of
signiﬁcant  artery  lesions  in  patients  referred  for  elective
valve  surgery.
M
os  droits  réservés.
ethods
tudy population
onsecutive  patients  scheduled  for  valve  surgery  were
creened  prospectively  from  August  2007  to  December  2010.
s  a  previous  study  had  shown  good  results  for  MSCT
n  patients  with  aortic  stenosis  [6],  we  initially  excluded
atients  with  aortic  stenosis  in  order  to  explore  the  diagnos-
ic  accuracy  of  MSCT  in  patients  with  other  valve  diseases.
owever,  owing  to  low  patient  numbers,  from  mid-2008  we
lso  included  patients  with  aortic  stenosis.  Exclusion  criteria
ncluded:  atrial  ﬁbrillation,  previous  coronary  artery  bypass
raft  (CABG),  an  unstable  haemodynamic  state,  acute  renal
nsufﬁciency,  previous  allergic  reaction  to  iodine  contrast
edia,  pregnancy  and  lactation.  The  study  was  approved  by
he  French  Society  of  Cardiology;  and  all  patients  signed  an
nformed  consent  form.SCT  and  CA  were  performed  in  all  patients  within  3  weeks
f  each  other.  All  patients  with  baseline  heart  rate  greater
426  
Table  1  Patient  characteristics.
All  patients  (n  =  48)
Men 30 (62.5)
Age  (years)  63  (55—74)
Valvular  heart  diseasea
Aortic  insufﬁciency  20  (37.7)
Aortic  stenosis  17  (32.1)
Mitral  regurgitation 11  (20.7)
Mitral  stenosis 5  (9.4)
Reoperation 2  (4.1)
Creatinine  clearance  (mL/kg/min) 55  (45—66)
Risk  factors
Hypertensionb 26  (54.2)
Hypercholesterolaemiac 20  (41.7)
Smoker  7  (14.6)
Ex-smoker  21  (43.8)
Family  history  of  CAD  13  (27.1)
BMI  ≥  25  kg/m2 25  (52.1)
Diabetes  mellitus  4  (8.3)
Previous  myocardial  infarction  1  (2.1)
[5pt]  Prior  percutaneous  coronary
intervention
9 (18.8)
Left  ventricular  ejection  fraction
(%)
56 (47—65)
Distribution  of  disease  by  CA
None  35  (72.9)
1  vessel  8  (16.7)
2  vessels  2  (4.2)
3  vessels  3  (6.3)
MSCT  dose  length  product
(mGy  cm)
1190 (1032—1791)
MSCT  contrast  agent  (mL)  120  (95—125)
CA  dose  length  product  (mGy  cm)  416  (267—675)
Baseline  treatment  (%)d
Beta-blocker  13  (33.3)
Diuretic  14  (35.9)
Data are number (%) or median (interquartile range). BMI: body
mass index; CA: coronary angiography; CAD: coronary artery
disease; MSCT: multislice computed tomography.
a Patients could have more than one type of disease.
b Blood pressure ≥ 140/90 mmHg or treatment for hypertension.


























































Rd Data from 39 patients.
han  65  beats  per  minute  received  5  to  10  mg  of  intravenous
tenolol  10  min  before  the  examination.
SCT protocol
ll  scans  were  performed  using  a  64-slice  MSCT  (Philips,  Bril-
iance  64  CT  scanner,  Eindhoven,  Holland).  The  scan  protocol
ncluded  slices  of  the  aortic  artery  for  10  patients  for  whom
 transcatheter  aortic  valve  implantation  was  discussed.
hus,  the  median  radiation  exposure  for  MSCT  with  this  scan
P
O
iR.  Jakamy  et  al.
rotocol  was  calculated  as  16  mSv,  although  prospective  X-
ay  tube  modulation  was  used.  A  standardized  examination
rotocol,  with  64  ×  0.625  mm  collimation,  pitch  of  0.2  and
 tube  rotation  time  of  400  ms,  was  used.  The  typical  tube
oltage  was  120  kV,  with  a  tube  current  of  600—900  mAs,
epending  on  patient  size,  body  mass  index  and  thoracic
iameters  in  the  scan  area.  A  mean  of  114  ±  23  mL  of  iodine
ontrast  agent  (400  mgI/mL,  Iomeron,  Bracco,  Milan,  Italy)
as  injected  continuously  at  a  rate  of  8  mL/s  to  explore
olely  the  coronary  arteries.  A  bolus  tracking  technique  with
utomated  detection  of  peak  enhancement  in  the  ascending
orta  was  used  to  time  the  scan.  Coronary  assessment  was
one  during  a  single  breath-hold.
Radiologists  used  multiplanar  reformations  and  three-
imensional  reconstructions  to  detect  signiﬁcant  coronary
tenoses,  deﬁned  as  a mean  lumen  reduction  greater  than
0%.  They  used  the  17-segment  American  Heart  Association
AHA)  classiﬁcation  [7]  to  describe  coronary  lesions  and  they
ere  blinded  to  clinical  data.  All  vessels  were  included  in
he  analysis,  and  any  that  were  uninterpretable  were  scored
s  signiﬁcant  coronary  stenoses.
oronary angiography
oronary  angiograms  were  analysed  by  one  experienced  car-
iologist  [H.G.],  who  was  unaware  of  the  MSCT  results,
sing  a  modiﬁed  17-segment  AHA  classiﬁcation  [7].  All  coro-
ary  segments  were  visually  assessed.  Those  with  signiﬁcant
arrowing  were  quantiﬁed  by  a  validated  QCA  algorithm
CAAS,  Pie  Medical,  Maastricht,  The  Netherlands).  They
ere  evaluated  in  two  orthogonal  views,  and  were  classi-
ed  as  signiﬁcant  if  the  mean  lumen  diameter  reduction  was
reater  than  50%.
tatistical methods
he  diagnostic  accuracy  of  MSCT  was  compared  with  that  of
A  as  the  reference  standard  for  the  detection  of  signiﬁcant
tenosis  in  the  coronary  arteries.  All  diagnostic  accuracy
arameters,  sensitivity,  speciﬁcity,  positive  and  negative
redictive  values,  and  positive  and  negative  likelihood  ratios
re  given  with  their  corresponding  95%  conﬁdence  intervals
CIs).  Interobserver  agreement  was  assessed  by  Cohen  Kappa
tatistics,  and  was  performed  for  four  analyses:  by  patient,
y  revascularization,  by  vessel  and  by  segment.
Continuous  variables  are  reported  as  medians  and
nterquartile  ranges  (IQRs),  and  categorical  variables  as
umbers  and  percentages.  Comparisons  between  patients
ith  and  without  aortic  stenosis  were  performed  using
tudent’s  t  test  for  independent  samples  for  continuous
ariables,  and  a  2 test  or  Fisher’s  exact  test  when  appro-
riate  for  categorical  variables.  A P  value  less  than  0.05
as  considered  signiﬁcant.  All  analyses  used  XLSTAT  Version
011.2.08  (Addinsoft  Inc.,  New  York,  NY,  USA).
esultsatient characteristics
f  66  consecutive  patients  scheduled  for  valve  surgery  dur-

















































aMSCT  for  assessing  coronary  disease  before  heart  valve  surg
limited  patient  and  time  availability  to  perform  MSCT  before
surgery  (n  =  11),  withdrawal  of  written  consent  (n  =  5),  acute
renal  insufﬁciency  (n  =  1)  and  previous  allergic  reaction  to
iodine  contrast  media  (n  =  1).  Demographics  of  the  remain-
ing  48  patients  are  shown  in  Table  1.  Most  patients  had
aortic  insufﬁciency  (37.7%)  or  aortic  stenosis  (32.1%);  ﬁve
patients  had  a  double  valvular  disease.  Approximately  half
of  the  patients  were  overweight,  had  hypertension,  were
(ex)-smokers,  and  had  a  left  ventricular  ejection  fraction
greater  than  56%  (Table  1).  The  prevalence  of  CAD  was
27.1%,  mainly  one-vessel  disease  (16.7%)  (Table  1).
Patient-based analysis
MSCT  correctly  excluded  CAD  in  31  patients,  with  a  speci-
ﬁcity  of  89%  (Table  2).  Four  patients  classiﬁed  as  having
signiﬁcant  coronary  lesions  had  the  severity  of  stenoses
overestimated.  MSCT  correctly  identiﬁed  signiﬁcant  coro-
nary  lesions  in  10  of  13  patients,  resulting  in  a  sensitivity
of  77%.  The  diagnostic  accuracy  of  a  normal  MSCT  to
detect  patients  without  signiﬁcant  stenosis  was  91%.  The
agreement  on  the  presence  of  signiﬁcant  coronary  lesions
between  the  MSCT  and  CA  was  good  (К  value  0.64).
Revascularization-based analysis
Preoperative  CA  led  to  revascularization  (CABG  or  percuta-
neous  coronary  intervention)  in  11  of  48  patients  (22.9%)
(Table  2).  Nine  patients  were  correctly  detected  by  MSCT,
giving  a  sensitivity  of  82%.  Among  the  ﬁve  patients  scored
false  positive,  two  were  lost  to  follow-up.  The  speciﬁcity  of
86%  would  have  prevented  32  CAs.  The  agreement  between
MSCT  and  CA  to  detect  patients  requiring  coronary  revascu-
larization  was  good  (К  value  0.62).
Valve disease-based analysis
Ten  patients  with  severe  aortic  stenosis  had  signiﬁcant  coro-
nary  lesions  (59%)  (Table  2).  Two  of  these  patients  were
classiﬁed  as  false  negatives,  resulting  in  a  sensitivity  of  80%.
Speciﬁcity  and  negative  predictive  values  were  86%  and  75%,
respectively.  Agreement  coefﬁcient  К  was  0.64,  suggesting
a  good  correlation  between  MSCT  and  CA.
Among  patients  with  severe  aortic  insufﬁciency,  the
negative  and  positive  predictive  values  were  100%  and  33%,
respectively  (Table  2).  MSCT  correctly  identiﬁed  no  sig-
niﬁcant  coronary  lesions  for  the  ﬁve  patients  with  mitral
stenosis,  resulting  in  speciﬁcity  and  negative  predictive  val-
ues  of  100%.  Only  one  of  11  patients  with  severe  mitral
regurgitation  was  classiﬁed  as  false  negative.  The  sensitiv-
ity,  speciﬁcity,  positive  and  negative  predictive  values  were
50%,  89%,  50%  and  89%,  respectively.
Table  3  shows  the  comparison  of  the  baseline  characte-
ristics  of  patients  with  and  without  aortic  stenosis.  Patients
with  aortic  stenosis  were  signiﬁcantly  older  and  signiﬁcantly
more  likely  to  have  CAD,  hypertension  and  hypercholestero-
laemia.Vessel-based analysis
By  MSCT,  163  of  192  vessels  were  correctly  analysed  as  being





y  the  six  false  negatives.  Three  of  the  six  lesions  not
etected  by  MSCT  were  in  the  circumﬂex  artery.  The  seve-
ity  of  stenosis  was  overestimated  in  11  arteries  (one  in  the
eft  main  artery,  four  in  the  left  anterior  descending  artery
nd  six  in  the  right  coronary  artery),  which  were  classiﬁed  as
alse  positives.  However,  the  speciﬁcity  and  negative  predic-
ive  values  were  94%  and  97%,  respectively.  Cohen’s  Kappa
oefﬁcient  was  0.54,  indicating  a  good  agreement  between
he  results  of  CA  and  MSCT  to  detect  signiﬁcant  coronary
esions  on  a  per-vessel  analysis.
egment-based analysis
o  segments  were  excluded  from  the  analysis,  thus  720
egments  were  included  for  comparison  with  CA.  Eight  sig-
iﬁcant  coronary  stenoses  in  CA  were  underestimated  by
SCT  (Table  2),  mainly  in  the  distal  epicardial  trunks.  The
ensitivity  and  positive  predictive  values  were  65%  and
2%  respectively.  MSCT  overestimated  14  coronary  stenoses,
onsidered  false  positives,  including  ten  uninterpretable
egments.  The  speciﬁcity  and  negative  predictive  values
ere  98%  and  99%  respectively.
The  positive  likelihood  ratio  of  32  indicates  a  signiﬁ-
ant  change  in  post-test  odds  to  detect  signiﬁcant  coronary
tenoses.  The  interobserver  variability  for  the  detection  of
igniﬁcant  stenoses  in  segments  had  a moderate  value  К of
.56.
maging
ig.  1  shows  volume-rendered  and  multiplanar  recon-
tructed  MSCT  images  and  the  corresponding  CA  image  from
 patient  who  had  a  mitral  regurgitation.  The  arrow  shows  a
igniﬁcant  stenosis  in  the  proximal  left  anterior  descending
rtery,  correctly  identiﬁed  by  MSCT.
iscussion
n  our  study,  MSCT  was  correct  in  31  of  35  patients  free
f  CAD  and  in  ten  of  13  patients  with  signiﬁcant  coronary
esions.  The  severity  of  the  stenosis  was  underestimated  in
hree  patients  and  overestimated  in  four  patients,  there-
ore,  CA  could  have  been  avoided  in  31  of  48  patients
64.5%).
The  27.1%  prevalence  of  CAD  in  our  study  is  high  com-
ared  with  that  reported  in  previous  studies  (approximately
0%  [6,8]), and  ensures  the  inclusion  of  patients  with  a  high
re-test  probability  of  CAD.  MSCT  allowed  the  detection  of
igniﬁcant  coronary  stenoses,  with  a  good  sensitivity  of  77%
nd  a  high  speciﬁcity  of  88%.  The  detection  was  correct  in
1  of  48  patients  (85.4%).  Of  the  three  patients  classiﬁed  as
alse  negatives,  two  had  severe  aortic  stenosis,  resulting  in  a
egative  predictive  value  among  patients  with  aortic  steno-
is  that  was  lower  (75%)  than  reported  in  previous  studies
100%  [6,8]).
CAD  is  found  in  approximately  one-third  of  patients  with
ortic  stenosis  [9],  but  in  our  study,  the  prevalence  of  CAD
as  much  higher  (59%).  The  prevalence  of  a  disease  strongly
nﬂuences  the  positive  and  negative  predictive  values  of  a
iagnostic  test  [10]. Thus,  the  high  prevalence  tended  to








Table  2  Diagnostic  performance  of  MSCT  for  the  detection  of  stenoses  greater  than  50%  on  CA.










Kappa  Sensitivitya Speciﬁcitya PPVa NPVa +LRb —LRb
Patient  27.1  48  10  31  4  3  0.64  77  (49—92)  89  (73—96)  71  (47—95)  91  (81—100)  6.7  (2.5—17.7)  0.2  (0.1—0.7)
Revascularizationc 22.9  48  9  32  5  2  0.62  82  (51—95)  86  (71—94)  64  (40—90)  94  (86—100)  6  (2.5—14)  0.2  (0—0.7)
Valvular  heart  disease
AS 58.8  17  8  6  1  2  0.64  80  (47—95)  86  (46—100)  89  (68—100)  75  (45—100)  5.6  (0.9—35)  0.2  (0—0.8)
AI  5.0  20  1  17  2  0  0.46  100  (17—100)  89  (67—98)  33  (0—86)  100  (100—100)  9.5  (2.5—35)  0
MS  0  5  0  5  0  0  —  —  100  (50—100)  —  100  (100—100)  —  —
MR  18.2  11  1  8  1  1  0.40  50  (10—90)  89  (54—100)  50  (0—100)  89  (60—100)  4.5  (0.4—45)  0.5  (0.1—2)
Coronary  arteries 9.4 192  12  163  11  6  0.54  67  (41—86)  94  (89—96)  52  (31—72)  97  (92—98)  10.6  (5.4—20)  0.3  (0.2—0.7)
LM  0  48  0  47  1  0  —  —  98  (89—100)  —  100  (100—100)  —  —
LAD  14.6  48  6  37  4  1  0.64  85  (46—99)  90  (76—96)  60  (30—90)  97  (92—100)  8.3  (3.3—23)  0.1  (0—0.9)
Cx  10.4  48  2  43  0  3  0.54  40  (12—76)  100  (92—100)  100  (100—100)  93  (86—100)  —  0.6  (0.3—1.2)
RCA  12.5  48  4  36  6  2  0.40  66  (30—90)  85  (71—93)  40  (9—70)  94  (87—100)  4.6  (1.8—12)  0.4  (0.1—1.2)
Segment 3.2  720  15  683  14  8  0.56  65  (44—81)  98  (96—99)  52  (33—70)  99  (98—99)  32  (17—59)  0.3  (0.2—0.6)
+LR: positive likelihood ratio; —LR: negative likelihood ratio; AI: aortic insufﬁciency; AS: aortic stenosis; Cx: circumﬂex; FN: false negative; FP: false positive; LAD: left anterior descending;
LM: left main; MR: mitral regurgitation; MS: mitral stenosis; NPV: negative predictive value; PPV: positive predictive value; RCA: right coronary artery; TN: true negative; TP true positive.
a Data are % (95% conﬁdence interval).
b Data are ratio (95% conﬁdence interval).
c Revascularization by coronary artery bypass graft or percutaneous coronary intervention.
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Table  3  Comparison  between  patients  with  and  without  AS.
AS  (n  =  17)  Not  AS  (n  =  31)  Pa
Men 12 (70.5)  18  (58)  0.39
Age  (years)  70  ±  12  62  ±  11  0.013b
Prevalence  of  CAD  10  (59)  3  (9.6)  0
BMI  (kg/m2)  25.5  ±  4  26.5  ±  2  0.68b
Risk  factors
Hypertensionc 13  (76.4)  13  (41.9)  0.022
Hypercholesterolaemiad 11  (64.7)  9  (29)  0.017
Smoker 2  (11.7) 5  (16.1)  0.52e
Ex-smoker 10  (58.8) 11  (35.4) 0.11
Family  history  of  CAD  4  (23.5)  9  (29)  0.47e
Diabetes  mellitus  1  (5.8)  3  (9.6)  0.55e
Previous  myocardial  infarction  0  1  (3.2)  0.64e
Prior  percutaneous  coronary  intervention  3  (17.6)  6  (19.3)  0.6e
Reoperation  1  (5.8)  1  (3.2)  0.58e
Treatment  with  beta-blocker  and/or  calcium  inhibitorsf 4  (26.6)  9  (37.5)  0.44e
Data are number (%) or mean and standard deviation. AS: aortic stenosis; BMI: body mass index; CAD: coronary artery disease; VHD:
valvular heart disease.
a 2 test unless otherwise indicated.
b Student’s t test for two independent samples.
c Blood pressure ≥ 140/90 mmHg or treatment for hypertension.
d Total cholesterol ≥ 180 mg/dL or treatment for hypercholesterolaemia.























SData from 15 patients with AS and 24 without AS.
Coronary  calciﬁcations  increase  with  age  as  well  as  the
prevalence  of  CAD  [11]. Their  degree  has  a  linear  associ-
ation  with  aortic  valve  calciﬁcations  [12]. Among  patients
with  aortic  stenosis,  the  lesions  of  the  circumﬂex  and  right
coronary  arteries  could  not  be  correctly  assessed  because  of
calciﬁcations.  They  were  underestimated  (false  negatives),
which  explains  the  low  negative  predictive  value  (75%).
Patients  with  aortic  insufﬁciency  were  younger,  with  fewer
valve  calciﬁcations,  hence,  an  excellent  negative  predictive
value  of  100%.
As in  previous  studies,  we  chose  to  include  all  seg-
ments  and  score  uninterpretable  coronary  lesions  on  MSCT
as  signiﬁcant  coronary  stenoses,  at  the  risk  of  obtaining
low  speciﬁcity  and  positive  predictive  values  [13]. However,
the  speciﬁcity  of  98%  and  negative  predictive  value  of  99%
were  very  high,  proving  the  excellent  diagnostic  accuracy
of  MSCT  to  detect  vessels  without  signiﬁcant  stenosis.  The
high  diagnostic  accuracy  of  MSCT  is  mainly  due  to  its  neg-
ative  predictive  value  for  the  exclusion  of  CAD  [14]. Our
results  conﬁrm  the  high  diagnostic  accuracy  for  excluding
coronary  artery  disease  in  patients  with  a  scheduled  heart
valve  surgery.
The  analysis  by  revascularization  provides  data  that  are
more  realistic  in  terms  of  usual  clinical  practice.  With  two
patients  lost  to  follow-up,  11  coronary  patients  (22.9%)
underwent  revascularization  with  CABG  or  coronary  angio-
plasty,  but  the  negative  predictive  value  of  MSCT  remained
high.  Over  half  of  signiﬁcant  coronary  stenoses  do  not  have




ton-ischaemic  coronary  lesions  does  not  have  a  beneﬁcial
mpact  on  morbidity  and  mortality  [17]. Even  when  detect-
ng  signiﬁcant  coronary  stenoses,  MSCT  cannot  be  used
o  judge  the  beneﬁt  of  revascularization.  It  is  disappoint-
ng  that  the  data  according  to  revascularization  were  not
ncluded  in  previous  studies  [4,6]. Having  information  from
 larger  number  of  patients  would  be  more  informative  than
imply  a  comparison  with  the  results  of  CA,  since  we  have
o  deal  with  both  patients  lost  to  follow-up  and  with  dis-
al  signiﬁcant  coronary  stenosis  requiring  medical  treatment
ithout  a  revascularization  procedure.
Radiation  exposure  with  MSCT  is  higher  than  with  CA  [19].
espite  the  use  of  prospective  X-ray  tube  modulation,  which
an  reduce  radiation  exposure  by  50%,  our  mean  effective
ose  was  very  high  (20  ±  10  mSv).  The  main  reason  for  this  is
hat  our  acquisition  protocol  was  not  focused  solely  on  the
oronary  arteries,  but  also  associated  aortic  artery  slices
n  10  of  48  patients  (20.8%)  with  aortic  stenosis,  for  whom
 transcatheter  aortic  valve  implantation  was  discussed.
especting  the  acquisition  protocol,  one  can  obtain  lower
ffective  doses  (mean  8.6  ±  2.8  mSv  for  a  64-slice  MSCT
20]).
tudy limitationsne  limitation  to  our  study  is  the  exclusion  of  patients
ith  atrial  ﬁbrillation,  haemodynamic  instability,  previous
evascularization  by  CABG  and  kidney  failure.  Atrial  ﬁbrilla-
ion  has  long  been  considered  a  hindrance  to  the  quality  of
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Rigniﬁcant stenosis in the proximal left anterior descending artery (
SCT  images.  However,  recent  studies  have  demonstrated
 lack  of  consequence  of  an  irregular  rhythm  on  image
nterpretation  with  MSCT  [4,8]. Therefore,  atrial  ﬁbrillation
s  no  longer  a  concern  with  MSCT  using  electrocardio-
raphic  gating  for  image  reconstruction  to  obtain  nearly
otion-free  image  quality.  Too  many  exclusion  criteria  tend
o  decrease  the  number  of  false  positives  and  wrongly
avour  the  speciﬁcity  and  positive  predictive  value  of  the
tudy  [15]. Selection  biases  may  limit  the  generalization  of
SCT.
Previous  studies  have  shown  great  interest  in  ﬁnding  the
ost  accurate  Agatston  score  threshold  for  recommending
SCT  as  a  ﬁrst-line  means  of  ruling  out  CAD  [5,18]. However,
e  did  not  collect  data  for  the  quantiﬁcation  of  coronary
alcium  score.
onclusions
n  these  patients  referred  for  elective  valve  surgery,
SCT  had  a  high  diagnostic  accuracy  to  rule  out  sig-
iﬁcant  coronary  stenoses.  However,  larger  multicentre
tudies  in  an  unselected  population  of  patients  are  needed
o  determine  its  place  within  the  range  of  diagnostic
ools  for  the  preoperative  assessment  of  valvular  heart
isease.d C); and corresponding coronary angiogram image (D).
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